Last reviewed · How we verify

NCT04191902: SMS

Educational Intervention Using SMS to Evaluate Clinical Effects and Satisfaction in Patients With Diabetes Mellitus

Status unknown Last updated 6 November 2020
What this trial tests

trial testing orientation in Educational Problems in 50 participants. Status unknown.

Timeline
5 January 2021
Primary endpoint
5 January 2022
15 February 2022

Quick facts

Lead sponsorUniversidade Federal Fluminense
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50
Start date5 January 2021
Primary completion5 January 2022
Estimated completion15 February 2022

Drugs / interventions tested

Conditions studied

Sponsor

Universidade Federal Fluminense — full company profile →

Who can join

Eligibility, any sex, with Educational Problems. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators evaluated the satisfaction of these patients with the health service and their self-care. The study included patients diagnosed with DM, respecting the established inclusion and exclusion criteria. Participants were randomized into the control group and the intervention group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Educating diabetic patients through an SMS intervention: a randomized controlled trial at a Brazilian public hospital.
    Aceti VM, Santoro RV, Velarde LGC, Brandão DN, et al · · 2021 · cited 5× · PMID 34283906 · DOI 10.20945/2359-3997000000390

Verify or expand the search:

Other recruiting trials for Educational Problems

Currently open trials in the same condition.

Other Universidade Federal Fluminense trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04191902.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing